Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Dietary Supplements
Systemic delivery of SapC-DOPS has antiangiogenic and antitumor effects against glioblastoma.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Systemic delivery of SapC-DOPS has antiangiogenic and antitumor effects against glioblastoma.
Systemic delivery of SapC-DOPS has antiangiogenic and antitumor effects against glioblastoma. Mol Ther. 2013 Aug; 21(8):1517-25.
View in:
PubMed
subject areas
Angiogenesis Inhibitors
Animals
Antineoplastic Agents
Blood-Brain Barrier
Brain Neoplasms
Cell Hypoxia
Cell Line, Tumor
Cell Membrane
Disease Models, Animal
Female
Glioblastoma
Humans
Male
Mice
Nanoparticles
Neovascularization, Physiologic
Phosphatidylserines
Recombinant Proteins
Saposins
Xenograft Model Antitumor Assays
authors with profiles
Michael C Ostrowski